Literature DB >> 15475352

Models of the cooperative mechanism for Rho effector recognition: implications for RhoA-mediated effector activation.

Lars Blumenstein1, Mohammad Reza Ahmadian.   

Abstract

Activated GTPases of the Rho family regulate a spectrum of functionally diverse downstream effectors, initiating a network of signal transduction pathways by interaction and activation of effector proteins. Although effectors are defined as proteins that selectively bind the GTP-bound state of the small GTPases, there have been also several indications for a nucleotide-independent binding mode. By characterizing the molecular mechanism of RhoA interaction with its effectors, we have determined the equilibrium dissociation constants of several Rho-binding domains of three different effector proteins (Rhotekin, ROCKI/ROK beta/p160ROCK, PRK1/PKNalpha where ROK is RhoA-binding kinase) for both RhoA.GDP and RhoA.GTP using fluorescence spectroscopy. In addition, we have identified two novel Rho-interacting domains in ROCKI, which bind RhoA with high affinity but not Cdc42 or Rac1. Our results, together with recent structural data, support the notion of multiple effector-binding sites in RhoA and strongly indicate a cooperative binding mechanism for PRK1 and ROCKI that may be the molecular basis of Rho-mediated effector activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15475352     DOI: 10.1074/jbc.M409551200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Always look on the bright site of Rho: structural implications for a conserved intermolecular interface.

Authors:  Radovan Dvorsky; Mohammad Reza Ahmadian
Journal:  EMBO Rep       Date:  2004-12       Impact factor: 8.807

Review 2.  Rho-kinase: regulation, (dys)function, and inhibition.

Authors:  Ehsan Amin; Badri Nath Dubey; Si-Cai Zhang; Lothar Gremer; Radovan Dvorsky; Jens M Moll; Mohamed S Taha; Luitgard Nagel-Steger; Roland P Piekorz; Avril V Somlyo; Mohammad R Ahmadian
Journal:  Biol Chem       Date:  2013-11       Impact factor: 3.915

Review 3.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

4.  A Salmonella typhimurium-translocated glycerophospholipid:cholesterol acyltransferase promotes virulence by binding to the RhoA protein switch regions.

Authors:  Doris L LaRock; Peter S Brzovic; Itay Levin; Marie-Pierre Blanc; Samuel I Miller
Journal:  J Biol Chem       Date:  2012-06-27       Impact factor: 5.157

5.  Characterization of the novel cardiolipin binding regions identified on the protease and lipid activated PKC-related kinase 1.

Authors:  Jason L J Lin
Journal:  Protein Sci       Date:  2019-06-19       Impact factor: 6.725

6.  Periodic propagating waves coordinate RhoGTPase network dynamics at the leading and trailing edges during cell migration.

Authors:  Alfonso Bolado-Carrancio; Oleksii S Rukhlenko; Elena Nikonova; Mikhail A Tsyganov; Anne Wheeler; Amaya Garcia-Munoz; Walter Kolch; Alex von Kriegsheim; Boris N Kholodenko
Journal:  Elife       Date:  2020-07-24       Impact factor: 8.140

7.  The Role of Ect2 Nuclear RhoGEF Activity in Ovarian Cancer Cell Transformation.

Authors:  Lauren P Huff; Molly J Decristo; Dimitri Trembath; Pei Fen Kuan; Margaret Yim; Jinsong Liu; Danielle R Cook; C Ryan Miller; Channing J Der; Adrienne D Cox
Journal:  Genes Cancer       Date:  2013-11

Review 8.  Single cell pattern formation and transient cytoskeletal arrays.

Authors:  William M Bement; George von Dassow
Journal:  Curr Opin Cell Biol       Date:  2013-10-23       Impact factor: 8.382

Review 9.  Applications for ROCK kinase inhibition.

Authors:  Michael F Olson
Journal:  Curr Opin Cell Biol       Date:  2008-02-20       Impact factor: 8.382

Review 10.  Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy.

Authors:  Nicola Rath; Michael F Olson
Journal:  EMBO Rep       Date:  2012-09-11       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.